Cargando…
Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model
Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agent...
Autores principales: | Sirait-Fischer, Evelyn, Olesch, Catherine, Fink, Annika F., Berkefeld, Matthias, Huard, Arnaud, Schmid, Tobias, Takeda, Kazuhiko, Brüne, Bernhard, Weigert, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513675/ https://www.ncbi.nlm.nih.gov/pubmed/33014872 http://dx.doi.org/10.3389/fonc.2020.01771 |
Ejemplares similares
-
Apc Mutation Enhances PyMT-Induced Mammary Tumorigenesis
por: Prosperi, Jenifer R., et al.
Publicado: (2011) -
Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model
por: Roselli, Séverine, et al.
Publicado: (2014) -
Endogenous myoglobin expression in mouse models of mammary carcinoma reduces hypoxia and metastasis in PyMT mice
por: Aboouf, Mostafa A., et al.
Publicado: (2023) -
Investigating the Role of Heparanase in Breast Cancer Development Utilising the MMTV-PyMT Murine Model of Mammary Carcinoma
por: Jayatilleke, Krishnath M., et al.
Publicado: (2023) -
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
por: Cai, Ying, et al.
Publicado: (2017)